The most expensive Australian peptide ad can be the one you should never have produced. Before commissioning a banner, decide whether the actual offer may be advertised to the public. A campaign budget, a sophisticated storefront or an overseas sales history cannot resolve that first gate.
Once eligibility is established, the marketing work becomes much clearer: choose a serviceable audience, explain an eligible product accurately and measure the Australian buying experience. This guide separates that useful work from assumptions that can waste an entire production cycle.
In this guide
Start with the TGA product assessment
The TGA’s peptide guidance distinguishes approved products from the many unapproved therapeutic peptide products promoted online. Its current guidance says public advertising of unapproved therapeutic goods and prescription-only medicines is generally unlawful. Confirm the actual classification and status rather than treating peptide as a single retail category. TGA: how therapeutic peptide products are regulated.
A finished cosmetic containing a peptide should be assessed on its own formulation, presentation and claims. Do not assume it shares the status of a therapeutic product with a similar ingredient name. Equally, describing a therapeutic offer as skincare or research does not settle its classification. Give the reviewer the real product and full sales context.
Review more than the paid advertisement
TGA social-media guidance covers promotional content across posts, comments, hashtags and paid activity. That matters when a restrained ad leads into a brand account or page carrying stronger promotional claims. Map the entire public journey before deciding the creative is ready. TGA social-media guidance.
Put a person in charge of the final published version and the material the business adds around it. A new caption, pinned response or creator endorsement can change what the audience understands. Do not treat a different channel or a different speaker as a way to promote an offer that failed the original eligibility review.
Write a go, hold or stop decision
| Decision | What the record says | Next useful action |
|---|---|---|
| Go | The specific product, audience and promotion have a documented eligible route. | Produce within the reviewed brief and check platform policy. |
| Hold | A classification, document or claim remains unresolved. | Assign an owner and resolve it before spending. |
| Stop | The proposed public promotion is ineligible. | Do not launch that offer; review lawful business options separately. |
Keep the decision product-specific. One ineligible SKU does not establish the status of every finished product in a brand, and one eligible SKU does not clear the whole catalog. Review the destination’s recommendations and navigation so the campaign does not quietly become a promotion of unreviewed offers.
Build an Australian offer you can fulfill
For an eligible product, test the store using the regions you plan to serve. Australia’s delivery geography makes a single promise worth checking carefully. Confirm stock location, dispatch time, carrier coverage, remote-area conditions and customer-service hours. Use the terms your operation can maintain rather than an estimate copied from another market.
Make the currency unmistakable and explain the checkout total. If goods ship from overseas, establish the lawful import and supply arrangement before treating international checkout as proof of availability. A carrier accepting a parcel is not an advertising permission. Ask who owns a failed delivery and how the customer receives an answer.
Make creative answer a real purchase question
Start with the approved product facts. For an illustrative eligible cosmetic, the creative could help a shopper understand package size or product texture. Use the image to make those facts clearer. Avoid inventing physiological outcomes because a molecular visual or a laboratory setting makes them feel plausible.
Check the Meta pharmaceutical policy as a separate launch gate. Local eligibility does not guarantee platform acceptance. Keep the submitted ad and destination version together so a later review can be investigated precisely.
- Use product facts that apply to the exact offer shown.
- Check the final crop and text size on a phone.
- Keep delivery qualifications close to delivery promises.
- Brief any external creator on the same boundaries as the brand team.
- Record which question each concept is intended to answer.
Read the result with local costs in view
A campaign can generate orders and still be commercially weak if shipping, returns or support consume the contribution. Read Australian orders separately from the rest of the business. Note the destinations served, completed deliveries and recurring support issues alongside advertising results.
Choose a review window that allows the business to see the relevant order outcomes. A click is early evidence; a delivered order with known costs is a more useful commercial result. The market-entry checklist helps connect that evidence to the decision to continue or expand.
Can a research label make consumer promotion acceptable?
Do not assume so. Product classification, intended use and the promotion itself still need assessment. A label is not a substitute for that review.
What should Adnoxx help the team manage?
A clear campaign workflow for eligible offers: preparation, status, reporting and the next action. Its account-management dashboard complements the business’s product review; it cannot grant a TGA permission or control Meta’s decision.
Editorial review: 11 October 2026. The linked TGA guidance includes its current peptide-specific position. Recheck it before launch and when the product or claims change.
